The term “sarcoma” is derived from Greek meaning “fleshy excrescence.” Rudolf Virchow worked to classify sarcomas as a distinct connective tissue cancer in the mid-19th century. 

Pathogenesis

  • Genetic mutations
    • Oncogenes commonly seen in sarcomas: CDK4, N-myc, ras-related genes
    • Synovial sarcomas: reciprocal translocation between SS18 and SSX genes
    • Liposarcoma: amplification of MDM2 oncogene
    • Myxoid liposarcoma: FUS-DDIT3
    • Alveolar rhabdomyosarcoma: PAX3-FOXO1
    • Desmoplastic small round cell tumors: EWS-WT1

Presentation

  • Painless mass (growing months-years; may have pain secondary to mass effect if large enough)
  • Sometimes will have trauma to the affect area
  • Physical exam notes
    • Firmness of mass
    • Whether mass is tethered to surrounding structure or mobile
    • Associated muscular weakness or nerve involvement

Workup

  • Imaging
    • MRI
      • Imaging of choice
      • T1, T2, STIR, and contrast provide details on diagnosis, tumor size, and extent of peritumoral edema (shown on STIR)
    • XR are appropriate for bone tumors
  • Histology
    • After imaging, histologic confirmation is needed with biopsy. Histology is the most important part in determining how a sarcoma will behave in the future (please note that Grade used to be the most important part).
    • Completed using either ultrasound or CT guidance
    • Approaches
      • Core needle biopsy
        • Procedure of choice for diagnosis of bony or soft tissue mass
      • Fine-needle aspiration (FNA)
        • Can be used but may not provide enough tissue for diagnosis
      • Excisional biopsy
        • Must plan incision with future surgical procedures in mind
        • Incisions created along long axis of limb with ability to resect it during future surgeries
        • Consider for tumors <3 cm

Staging

  • Imaging of the entire area where the tumor is located
  • Myxoid liposarcoma → CT A/P (common to metastasize to abdomen, retroperitoneum, axial spine)
  • Epithelioid sarcoma, angiosarcoma, leiomyosarcoma → CT A/P
  • Alveolar soft part sarcoma, angiosarcoma → MRI  brain
  • Consider ultrasound for histologies that are common to metastasize to lymph nodes
    • Clear cell
    • Angiosarcoma
    • Rhabdomyosarcoma
    • Epithelioid sarcoma
  • Metastatic disease evaluation
    • CT chest w or wo contrast
    • Whole-body PET/CT is also an option
    • CXR may be sufficient for tumors with low metastatic potential
  • American Cancer Society: Stages of Soft Tissue Sarcomas

Treatment

  • Three pillars → radiation, chemotherapy, surgery
  • Radiation
  • Chemotherapy
    • Indications
      • High risk of metastatic disease
        • High-grade tumors like leiomyosarcoma or dedifferentiated liposarcoma >5 cm in size
        • Confirmed metastatic disease 
    • Neoadjuvant chemotherapy
      • Shrink tumor allowing for easier surgical resection
      • Early treatment of micrometastatic disease
  • Surgery
    • Consider functional status of the patient 
    • Goals
      • Circumferential margins of 1-2 cm of grossly normal tissue
      • Place clips to guide radiation therapy 
    • Options
      • Wide excision
      • Multicompartmental resections 
      • Amputation
      • Sentinel lymph node biopsy is considered for high-risk subtypes
    • Notes
      • Superficial fascia can be left if the tumor is superficial to fascia
      • Rim of underlying muscle is taken if fascia is involved 
      • Periosteal stripping is done to elevate tumor and eliminate need for bony resection

Relevant Information

  • Sarcoma by metastatic potential
    • Low
      • Atypical lipomatous tumor/well-differentiated liposarcoma
      • Dermatofibrosarcoma protuberans (DFSP)
      • Desmod tumor
    • Intermediate
      • Myxoid liposarcoma
      • Myxofibrosarcoma
      • Extraskeletal chondrosarcoma
      • Solitary fibrous tumor (hemangiopericytoma)
    • High
      • Alveolar soft part sarcoma
      • Angiosarcoma
      • Clear cell sarcoma
      • Dedifferentiated liposarcoma
      • Epithelioid sarcoma
      • Extraskeletal Ewing sarcoma
      • Extraskeletal osteosarcoma
      • Leiomyosarcoma
      • Malignant peripheral nerve sheath tumor (MPNST)
      • Neurogenic sarcoma (malignant schwannoma)
      • Pleomorphic liposarcoma
      • Rhabdomyosarcoma
      • Synovial sarcoma
      • Undifferentiated pleomorphic sarcoma
  • Survival at five years is 65%
  • Local recurrence is seen 10-20% of the time, most commonly in first 2 years after surgery
  • Distant metastatic disease is seen 40-50% of patients with intermediate and high-grade tumors. Most common site of metastasis is lung, followed by liver, bone, and subcutaneous metastases.

Complications

  • Infection
  • Bleeding
  • Hematoma
  • Seroma formation
  • Wound problems